Patents by Inventor Bo Akerstrom

Bo Akerstrom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ALPHA-1-MICROGLOBULIN FOR USE IN THE PROTECTION OF KIDNEYS IN RADIONUCLIDE THERAPY
    Publication number: 20180243369
    Abstract: This invention relates to ?1-microglobulin (A1M) for use in the diagnosis or treatment of malignancies requiring radionuclide diagnostics (RD), radionuclide therapy (RNT) or radioimmunotherapy (RIT), respectively, wherein A1M is used as a co-treatment to RD, RNT or RIT.
    Type: Application
    Filed: February 25, 2016
    Publication date: August 30, 2018
    Applicant: A1M PHARMA AB
    Inventors: Bo Akerstrom, Sven-Erik STRAND, Magnus Göran GRAM, Amanda Thuy TRAN
  • Diagnosis and treatment of preeclampsia
    Patent number: 8568999
    Abstract: The present invention relates to biomarkers for preeclampsia as well as treatment of this disease. In particular, the invention relates to methods for diagnosis or aiding in the diagnosis of preeclampsia of a pregnant female mammal to detect elevated levels of free haemoglobin, particularly free fetal haemoglobin. This facilitates and makes possible early diagnosis and clinical intervention when a preeclamptic condition is found. In addition, the invention relates to a method to treat female mammals with preeclampsia with the purpose to reverse the pathological conditions associated with this disease.
    Type: Grant
    Filed: February 12, 2008
    Date of Patent: October 29, 2013
    Assignee: A1M Pharma AB
    Inventors: Stefan Hansson, Bo Akerstrom
  • HbF AND A1M AS EARLY STAGE MARKERS FOR PREECLAMPSIA
    Publication number: 20130122529
    Abstract: A method for diagnosing or predicting the risk of developing preeclampsia by measuring the level of A1 M and one or more of the compounds HbA, HbF in a sample and comparing the obtained values with reference values. By using a combination of information relating to A1 M and HbF improved diagnose or prediction is observed.
    Type: Application
    Filed: March 24, 2011
    Publication date: May 16, 2013
    Applicant: Preelumina Diagnostics AB
    Inventors: Bo Akerstrom, Magnus Gram, Stefan Hansson
  • DIAGNOSIS AND TREATMENT OF PREECLAMPSIA
    Publication number: 20100105070
    Abstract: The present invention relates to biomarkers for preeclampsia as well as treatment of this disease. In particular, the invention relates to methods for diagnosis or aiding in the diagnosis of preeclampsia of a pregnant female mammal to detect elevated levels of free haemoglobin, particularly free fetal haemoglobin. This facilitates and makes possible early diagnosis and clinical intervention when a preeclamptic condition is found. In addition, the invention relates to a method to treat female mammals with preeclampsia with the purpose to reverse the pathological conditions associated with this disease.
    Type: Application
    Filed: February 12, 2008
    Publication date: April 29, 2010
    Inventors: Stefan Hansson, Bo Akerstrom